Cargando…
Ameliorative Potential of Donepezil with or without Prednisolone in Bleomycin-Induced Pulmonary Fibrosis in Rats: Involvement of the Anti-Inflammatory, Antioxidant, and the Antifibrotic Pathways
Background and Objectives: Bleomycin-induced pulmonary fibrosis is one of the serious complications that may limit the use of bleomycin in cancer therapy. To date, there is no effective remedy for the amelioration of this condition. Donepezil, an anti-Alzheimer’s medication, has recently been proven...
Autores principales: | Mina, Shery, Elfeky, Dina M., Kabel, Ahmed M., Hedya, Sabeha E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223402/ https://www.ncbi.nlm.nih.gov/pubmed/37241212 http://dx.doi.org/10.3390/medicina59050980 |
Ejemplares similares
-
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019) -
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Sheng, Hanjing, et al.
Publicado: (2022) -
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
por: Miao, Yang, et al.
Publicado: (2023) -
Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Wang, Xishuai, et al.
Publicado: (2021) -
Anti-Inflammatory and Antifibrotic Potential of Longidaze in Bleomycin-Induced Pulmonary Fibrosis
por: Pakhomova, Angelina, et al.
Publicado: (2023)